Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$2.06B
Total Bought:
$401.78M
Total Sold:
$1.40B
Net Transaction:
-$1.00B
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Oruka Therapeutics, Inc.(ORKA)4,148,4284,148,4280$394.81M$345.52M16.79%-$49.28M
Erasca, Inc.(ERAS)17,891,81220,089,932+2,198,120$327.78M$294.52M14.31%-$33.26M
Spyre Therapeutics, Inc.(SYRE)2,985,4482,485,448-500,000$265.05M$221.28M10.75%-$43.77M
Korsana Biosciences Inc04,549,585+4,549,585$0$145.59M7.07%+$145.59M
Savara Inc.(SVRA)14,745,94319,568,534+4,822,591$90.84M$100.97M4.91%+$10.14M
Ocular Therapeutix, Inc.(OCUL)10,346,92610,346,9260$101.61M$79.36M3.86%-$22.25M
Damora Therapeutics Inc03,603,595+3,603,595$0$76.68M3.73%+$76.68M
Dianthus Therapeutics, Inc.(DNTH)1,180,000822,020-357,980$115.03M$72.38M3.52%-$42.65M
Viridian Therapeutics, Inc.(VRDN)3,257,9173,257,9170$59.85M$67.08M3.26%+$7.23M
Vor Biopharma Inc.(VOR)3,041,7193,041,7190$56.00M$58.04M2.82%+$2.04M
Cogent Biosciences, Inc.(COGT)1,642,1661,642,1660$63.55M$52.58M2.55%-$10.97M
Adlai Nortye Group LtdADS3,212,7313,212,7310$36.95M$51.40M2.50%+$14.46M
Jade Biosciences Inc3,220,3643,220,3640$71.56M$45.25M2.20%-$26.31M
Achieve Life Science Inc2,751,0325,502,064+2,751,032$17.96M$44.51M2.16%+$26.55M
Maze Therapeutics, Inc.(MAZE)1,602,0341,545,616-56,418$47.80M$42.01M2.04%-$5.79M
Oric Pharmaceuticals Inc4,319,7652,944,056-1,375,709$46.78M$39.66M1.93%-$7.13M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$48.28M$35.02M1.70%-$13.26M
Adarx Pharmaceuticals Inc01,625,793+1,625,793$0$32.42M1.58%+$32.42M
Crescent Biopharma Inc.2,133,5762,133,734+158$38.40M$31.13M1.51%-$7.27M
Relmada Therapeutics Inc6,844,3057,445,050+600,745$47.36M$28.07M1.36%-$19.29M
Zura Bio LtdCL A6,434,9906,434,9900$37.97M$26.77M1.30%-$11.20M
X4 Pharmaceuticals Inc1,934,2537,644,072+5,709,819$9.03M$22.17M1.08%+$13.13M
Cullinan Therapeutics Inc1,379,9651,379,9650$25.13M$21.18M1.03%-$3.95M
Surrozen Inc632,931632,9310$16.42M$20.37M0.99%+$3.94M
Parabilis Medicines Inc625,000625,0000$17.11M$20.18M0.98%+$3.08M
Arvinas Inc01,952,533+1,952,533$0$15.10M0.73%+$15.10M
Century Therapeutics Inc8,695,6528,695,6520$21.30M$14.87M0.72%-$6.43M
Entera Bio LtdSHS05,106,337+5,106,337$0$14.86M0.72%+$14.86M
Artiva Biotherapeutics Inc2,043,5962,043,5960$19.82M$14.55M0.71%-$5.27M
Alto Neuroscience, Inc.(ANRO)500,000500,0000$13.20M$12.77M0.62%-$430.0K
Korro Bio Inc1,009,500443,431-566,069$13.31M$4.39M0.21%-$8.91M
Tcgx Acquisition CorpCL A0300,000+300,000$0$3.75M0.18%+$3.75M
Research Alliance Corp IvCL A0300,000+300,000$0$3.60M0.17%+$3.60M
Inmed Pharmaceuticals Inc32,685133,378+100,693$50.7K$181.4K0.01%+$130.7K
Apogee Therapeutics Inc8,493,3210-8,493,321$1.13B$0—-$1.13B
Helus Pharma Inc(HELP)3,851,6540-3,851,654$25.46M$0—-$25.46M
CytomX Therapeutics, Inc.(CTMX)4,982,1240-4,982,124$18.68M$0—-$18.68M
Damora Therapeutics, Inc.(DMRA)3,603,5950-3,603,595$93.73M$0—-$93.73M
Enliven Therapeutics Inc526,3310-526,331$26.71M$0—-$26.71M
Research Alliance Corp IiiCL A300,0000-300,000$3.21M$0—-$3.21M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q3 2026 | TickerTrail